Skip to main content

MARSHALL WACE, LLP

Position in EBS — Emergent BioSolutions Inc.

CIK 1318757 LONDON, X0

Position in EBS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$4,795,191
-$4,393,912 QoQ
Shares Held
577,734
-22.3% QoQ
Ownership
1.13%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2021
17 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in EBS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $609,159,561 across 30 Drug Manufacturers - Specialty & Generic names.

# Ticker Company Shares Value (USD) Open

All Filings in EBS

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $4,795,191 577,734
2025-12-31 $9,189,103 743,455
2025-09-30 $8,047,261 912,388
2025-06-30 $6,500,243 1,018,847
2025-03-31 $5,627,208 1,157,862
2024-12-31 $12,701,807 1,328,641
2024-09-30 $20,829,775 2,494,584
2024-06-30 $3,701,984 542,813
2024-03-31 $782,964 309,472
2023-12-31 $187,627 78,178
2023-09-30 $543,252 159,780
2023-06-30 $1,363,895 185,564
2023-03-31 $122,579 11,832
2022-06-30 $13,922,463 448,533
2021-12-31 $891,960 20,519
2021-09-30 $6,144,540 122,719
2021-06-30 $7,018,534 111,423